Nativis Voyager for Newly Diagnosed GBM
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 10
Summary
- Conditions
- Glioblastoma Multiforme
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Nativis Voyager combined with standard radiotherapy and temozolomideMasking: None (Open Label)Primary Purpose: Device Feasibility
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03276286
- Collaborators
- Not Provided
- Investigators
- Study Chair: Donna Morgan Murray, PhD Nativis, Inc.
Get Well Soon